top of page

Dernières nouvelles

Press Release

The Ottawa Hospital Research Institute

5 mars 2025

Network offers molecular testing of biliary tract cancers across Canada

Network offers molecular testing of biliary tract cancers across Canada
Featuring:

Rebecca Auer

Patient Experience

CHEK News

18 févr. 2025

Mom of two shares her battle with a rare and deadly cancer to help others

Mom of two shares her battle with a rare and deadly cancer to help others
Featuring:

Karla Bird

Caregiver Experience

OICR YouTube

11 févr. 2025

Cancer Research Changed My Life

Cancer Research Changed My Life
Featuring:

Ambuj Srivastava

Patient Experience

Patient Voice

22 nov. 2024

The dawn of a new era for Canadians living with cholangiocarcinoma

The dawn of a new era for Canadians living with cholangiocarcinoma
Featuring:

Jennifer Nielsen

Advocacy

The Newmarket Era, ON

21 nov. 2024

Newmarket woman’s battle over meds for rare cancer calls into question how province decides what drugs are covered under OHIP

Newmarket woman’s battle over meds for rare cancer calls into question how province decides what drugs are covered under OHIP
Featuring:

Heather Trombley

  • Facebook
  • Instagram
  • LinkedIn
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page